Skip to main content
Clinical Trials/NCT00559078
NCT00559078
Completed
Not Applicable

Health-related Quality of Life, Mental Health and Psychotherapeutic Considerations for Women Diagnosed With a Disorder of Sexual Development: Congenital Adrenal Hyperplasia

Lehigh University1 site in 1 country16 target enrollmentJuly 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Congenital Adrenal Hyperplasia
Sponsor
Lehigh University
Enrollment
16
Locations
1
Primary Endpoint
Telephone interview consisting of approximately 7 open ended questions addressing domains of HRQL, Mental Health and Support
Status
Completed
Last Updated
16 years ago

Overview

Brief Summary

This qualitative interview-based study will investigate the impact that living with congenital adrenal hyperplasia has for women in the following areas: health-related quality of life (HRQL), psychological health, and health-seeking behaviors.

Detailed Description

Congenital Adrenal Hyperplasia is a chronic-illness requiring life-long treatment and is caused by an inherited enzyme deficiency that leads to an overproduction of hormones produced by the adrenal glands, which in turn, masculinizes the female genitalia before birth. While the mechanisms by which CAH influences physiological development are understood, the impact of this hormonal elevation on health-related quality of life (HRQL), psychological health, and health-seeking behaviors is less clear. This study is guided by three research questions: (1) how does CAH influence HRQL domains (physical, functional, emotional and interpersonally), (2) how does CAH influence the mental health of women diagnosed with CAH, and (3) how does CAH influence decisions to seek help from a counselor? Semi-structured qualitative interviews will be conducted with women with CAH. Interviews will be analyzed through the Consensual Qualitative Research (CQR) methodology.

Registry
clinicaltrials.gov
Start Date
July 2007
End Date
May 2009
Last Updated
16 years ago
Study Type
Observational
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • 46XX, Females
  • Diagnosed by a physician with CAH (either simple-virilizing or salt-losing types)
  • Willing to complete a brief demographic questionnaire and participate in an hour long telephone interview

Exclusion Criteria

  • Non-classical or late-onset CAH

Outcomes

Primary Outcomes

Telephone interview consisting of approximately 7 open ended questions addressing domains of HRQL, Mental Health and Support

Time Frame: 1 hour

Secondary Outcomes

  • Demographic Questionnaire(15 minutes)

Study Sites (1)

Loading locations...

Similar Trials